Document Detail


Norcantharidin induces melanoma cell apoptosis through activation of TR3 dependent pathway.
MedLine Citation:
PMID:  22123174     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Norcantharidin (NCTD) has been reported to induce tumor cell apoptosis. However, the underlying mechanism behinds its antitumor effect remains elusive. We have previously shown that TR3 expression is significantly decreased in metastatic melanomas and involved in melanoma cell apoptosis. In this study, we showed that NCTD inhibited melanoma cell proliferation and induced apoptosis in a dose related manner. NCTD induced translocation of TR3 from nucleus to mitochondria where it co-localized with Bcl-2 in melanoma cells. NCTD also increased cytochome c release from mitochondria to the cytoplasm. These changes were accompanied by increased expression of Bax and cleaved caspase-3 along with decreased expression of Bcl2 and NF-κB2. The effects of NCTD were inhibited by knockdown of TR3 expression using TR3 specific shRNA in melanoma cells. Furthermore, NCTD significantly decreased tumor volume and improved survival of Tyr::CreER; BRAF(Ca/+); Pten(lox/lox) transgenic mice. Our data indicates that NCTD inhibits melanoma growth by inducing tumor cell apoptosis via activation of a TR3 dependent pathway. These results suggest that NCTD is a potential therapeutic agent for melanoma.
Authors:
Shujing Liu; Hong Yu; Suresh M Kumar; James S Martin; Zhanyong Bing; Weiqi Sheng; Marcus Bosenberg; Xiaowei Xu
Related Documents :
21932134 - Inclusive estimation of complex antigen presentation functions of monocyte-derived dend...
3277884 - Biology of interleukin 1.
11342664 - Il-18 gene transfer by adenovirus prevents the development of and reverses established ...
19188194 - The natural soluble form of il-18 receptor beta exacerbates collagen-induced arthritis ...
22149584 - Microbes, intestinal inflammation and probiotics.
22570864 - Secretory products of macrophages: twenty-five years on.
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Extramural     Date:  2011-12-01
Journal Detail:
Title:  Cancer biology & therapy     Volume:  12     ISSN:  1555-8576     ISO Abbreviation:  Cancer Biol. Ther.     Publication Date:  2011 Dec 
Date Detail:
Created Date:  2012-02-03     Completed Date:  2012-06-01     Revised Date:  2013-03-08    
Medline Journal Info:
Nlm Unique ID:  101137842     Medline TA:  Cancer Biol Ther     Country:  United States    
Other Details:
Languages:  eng     Pagination:  1005-14     Citation Subset:  IM    
Affiliation:
Department of Pathology, University of Pennsylvania School of Medicine, Philadelphia, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Animals
Antineoplastic Agents / pharmacology*
Apoptosis / drug effects*,  genetics
Bicyclo Compounds, Heterocyclic / pharmacology*
Cell Line, Tumor
Cell Proliferation
Humans
Melanoma / genetics,  metabolism*,  mortality
Mice
Mice, Transgenic
Mitochondria / metabolism
Nuclear Receptor Subfamily 4, Group A, Member 1 / genetics,  metabolism*
Protein Binding / drug effects
Protein Transport / drug effects
Proto-Oncogene Proteins c-bcl-2 / metabolism
Signal Transduction / drug effects*
Xenograft Model Antitumor Assays
Grant Support
ID/Acronym/Agency:
AR-054593/AR/NIAMS NIH HHS; CA-093372/CA/NCI NIH HHS; CA-116103/CA/NCI NIH HHS; R01 AR054593/AR/NIAMS NIH HHS; R01 AR054593-01A2/AR/NIAMS NIH HHS
Chemical
Reg. No./Substance:
0/Antineoplastic Agents; 0/Bicyclo Compounds, Heterocyclic; 0/Nuclear Receptor Subfamily 4, Group A, Member 1; 0/Proto-Oncogene Proteins c-bcl-2; 5442-12-6/norcantharidin
Comments/Corrections

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Brain natriuretic peptide in the evaluation of emergency department dyspnea: is there a role?
Next Document:  The combination of tephrosin with 2-deoxy-D-glucose enhances the cytotoxicity via accelerating ATP d...